SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-21-011405
Filing Date
2021-11-22
Accepted
2021-11-22 16:41:10
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_093021.htm   iXBRL 10-Q 1679015
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 16682
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 16356
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6420
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6423
  Complete submission text file 0001387131-21-011405.txt   7103418

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE admp-20210930.xsd EX-101.SCH 46959
7 XBRL CALCULATION FILE admp-20210930_cal.xml EX-101.CAL 92410
8 XBRL DEFINITION FILE admp-20210930_def.xml EX-101.DEF 192451
9 XBRL LABEL FILE admp-20210930_lab.xml EX-101.LAB 425556
10 XBRL PRESENTATION FILE admp-20210930_pre.xml EX-101.PRE 329760
11 EXTRACTED XBRL INSTANCE DOCUMENT admp-10q_093021_htm.xml XML 1161320
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 211433085
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences